New hope for tough prostate cancer: experimental drug AB-3028 enters human trials
NCT ID NCT07285694
First seen Jan 04, 2026 · Last updated May 12, 2026 · Updated 21 times
Summary
This study tests an experimental drug called AB-3028 in about 190 men whose prostate cancer has spread and stopped responding to standard hormone treatments. The main goal is to find a safe dose and see if the drug can shrink tumors or slow the disease. Participants must have a specific marker (PSMA) on their cancer cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope
RECRUITINGDuarte, California, 91010, United States
-
Perlmutter Cancer Center - NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
-
USC Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
-
University of Iowa and Holden Comprehensive Cancer Center
RECRUITINGIowa City, Iowa, 52242, United States
-
University of Minnesota
RECRUITINGMinneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.